NEW YORK, Nov. 15 – Large Scale Biology was issued nine new patents the company plans to use in its proteomics, functional genomics, and biomanufacturing operations, the company announced Thursday.

The patents issued to the Vacaville, Calif.-based company include US Patent No 6,254,834 for, according to the company, “distinguishing infectious agents, for identifying known viral pathogens, and for discovering and characterizing unknown viral pathogens.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.